trends in biopharma cold chain - flypharmaus.com€¦ · in 2018, cold chain is 18% of total pharma...
TRANSCRIPT
New products, new channels
Nick Basta, Pharmaceutical Commerce
TRENDS IN BIOPHARMA COLD CHAIN
21,000 SUBSCRIBERS; COMMERCIAL OPS, SALES/MARKETING, SUPPLY CHAIN, REGULATORY COMPLIANCE
The flow of products, information and revenue in the global biopharma industry
Quarterly magazine; annual Sourcebook
’Normal’ distribution
Pharmaceutical Supply Chain from a track-and-trace perspective
Packaging
CMOPallets are shippedSKU in cases
Cases on pallets
All uniquely identified
3PLSCarrier
Pallets or individual cases
get pulled or shipped
Cases and SKUs are
scanned & shipped to
customer
Distribution
Pharmacy
Serial number
scan
Gov
Customer
Distributor
Multiplying distribution channels
On the horizon: personalized cell/gene therapycredit: World Courier
Cold chain products have 2X non-cold-chain growth
In 2018, cold chain is 18% of total pharma spend
Cold chain spend is 71% transport, 29% pkg’g
Air and parcel is the dominant mode
Europe is the largest services market
Clinical trial logistics market is substantial, but slow-growing
Trends to watch:
• International movement is mostly pallet-scale, mostly active container; but passive options are multiplying
• CEIV Pharma program is growing in acceptance, but global practices still vary by country
• How much temperature-controlled CRT shipping? 5-15% in the US, higher in Europe with tighter GDP standards
• How fast will cell/gene therapies grow?
• More reuse of cold-chain packaging is in store: “Cold chain as a service”
• More real-time monitoring of temperature AND external parameters is being offered—but who owns the data?